SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

Press Releases Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Equities

1349

CNE1000000W4

Market Closed - Hong Kong S.E. Other stock markets 09:08:42 28/06/2024 BST			5-day change	1st Jan Change
1.79 ^HKD	+0.56%		-1.10%	-29.80%

06-21	Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial	MT
06-21	Shanghai Fudan Zhangjiang Bio-Pharmaceutical Terminates Libod Marketing Agreement	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Moderate to Severe Inflammatory Acne Vulgaris Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	27/10/23	AQ
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021	11/08/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : SUPPLEMENTAL CIRCULAR	06/05/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INDICATIVE ANNOUNCEMENT-FDA018 ANTIBODY DRUG CONJUGATE FOR INJECTION RECEIVED THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION	21/04/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : Circular	16/04/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : PROXY FORM FOR CLASS MEETING OF HOLDERS OF H SHARES	16/04/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : (1) PROPOSED ADOPTION OF THE 2021 RESTRICTED INCENTIVE SCHEME (2) CONNECTED TRANSACTION - PROPOSED ISSUE AND GRANT OF NEW A SHARES UNDER THE INCENTIVE SCHEME PURSUANT TO SPECIFIC MANDATE	06/04/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : DISCLOSEABLE TRANSACTION-ACQUISITION OF EQUITY INTERESTS AND CAPITAL INCREASE IN TARGET COMPANY	25/03/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : ADJUSTMENTS IN THE ROLES OF MEMBERS OF THE NOMINATION COMMITTEE	25/03/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : UTILISATION OF PART OF THE OVER SUBSCRIPTION PROCEEDS FROM A SHARE OFFERING FOR PERMANENT REPLENISHMENT OF WORKING CAPITAL	25/03/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION-PROPOSED GRANT OF GENERAL MANDATE TO THE BOARD OF DIRECTORS TO REPURCHASE H SHARES	25/03/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION - ANNOUNCEMENT OF PRELIMINARY ANNUAL RESULTS FOR THE YEAR 2020	25/02/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INDICATIVE ANNOUNCEMENT ON OBTAINING DRUG REGISTRATION CERTIFICATE (PARECOXIB SODIUM)	25/02/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : Interim Report For the Six Months Ended 30 June 2020	10/09/20	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : CIRCULAR	04/03/20	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : ARTICLES OF ASSOCIATION	24/02/20	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : POLL RESULTS OF EXTRAORDINARY GENERAL MEETING, CLASS MEETING OF HOLDERS OF H SHARES AND CLASS MEETING OF HOLDERS OF DOMESTIC SHARES	24/02/20	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : VOLUNTARY ANNOUNCEMENT-PRECAUTIONS DURING THE EPIDEMIC IN RELATION TO ATTENDANCE OF THE EXTRAORDINARY GENERAL MEETING, THE CLASS MEETING OF HOLDERS OF H SHARES AND THE CLASS MEETING OF HOLDERS OF DOMESTIC SHARES	17/02/20	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION-UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019	31/10/19	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : POLL RESULTS OF EXTRAORDINARY GENERAL MEETING	28/10/19	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Equities

1349

CNE1000000W4

Press Releases

Filters